Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Controlled Trial of a Strategy of Switching to Boosted PI Monotherapy Versus Continuing Combination ART for the Long-term Management of HIV-1 Infected Patients Who Have Achieved Sustained Virological Suppression on HAART

NCT01230580 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT01230580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01230580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Controlled Trial of a Strategy of Switching to Boosted PI Monotherapy Versus Continuing Combination ART for the Long-term Management of HIV-1 Infected Patients Who Have Achieved Sustained Virological Suppression on HAART
Lead sponsor
Medical Research Council
Phase
Phase 4
Overall status
Unknown status
Start date
November 30, 2008
Completion date
November 30, 2013
Enrollment
587 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acquired immunodeficiency syndrome, hiv infection